Novel humoral prognostic markers in small-cell lung carcinoma: A prospective study

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Gozzard, Paul ^a,c   Chapman, Caroline ^b   Vincent, Angela ^a   Lang, Bethan ^a   Maddison, Paul ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HU ANTIBODY; NEURONAL ANTIBODY; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; CANCER ANTIBODY; NERVE PROTEIN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEP 2 CELL LINE; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROSPECTIVE STUDY; RADIOIMMUNOPRECIPITATION; SEROLOGY; SMALL CELL LUNG CANCER; VERY ELDERLY; BLOOD; COMPLICATION; IMMUNOLOGY; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; RISK FACTOR; SMALL CELL LUNG CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, NEOPLASM; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SMALL CELL LUNG CARCINOMA;

EID: 84961294890     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143558     Document Type: Article

References (36)

1. Office for National Statistics. Cancer Statistics registrations: registrations of cancer diagnosed in 2006, England. 2009.
2. Lally BE, Urbanic JJ, Blackstock AW, Miller AA, Perry MC. Small cell lung cancer: have we made any progress over the last 25 years? Oncologist. 2007 Sep; 12(9):1096-104. PMID: 17914079
3. Kato Y, Ferguson TB, Bennett DE, Burford TH. Oat cell carcinoma of the lung. A review of 138 cases. Cancer. 1969 Mar; 23(3):517-24. PMID: 5766496
4. Flieder DB. Neuroendocrine tumors of the lung: recent developments in histopathology. Curr Opin Pulm Med. 2002 Jul; 8(4):275-80. PMID: 12055389
5. Roberts A, Perera S, Lang B, Vincent A, Newsom-Davis J. Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line. Nature. 1985 Oct 24-30; 317(6039):737-9. PMID: 2414666
6. Dorfman LJ, Forno LS. Paraneoplastic encephalomyelitis. Acta Neurol Scand. 1972; 48(5):556-74. PMID: 4643255
7. Hardy JD, Ewing HP, Neely WA, Stauss HK, Vance RB. Lung carcinoma: survey of 2286 cases with emphasis on small cell type. Ann Surg. 1981 May; 193(5):539-48. PMID: 6263195
8. Szabo A, Dalmau J, Manley G, Rosenfeld M, Wong E, Henson J, et al. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell. 1991 Oct 18; 67(2):325-33. PMID: 1655278
9. Dalmau J, Furneaux HM, Cordon-Cardo C, Posner JB. The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol. 1992 Oct; 141(4):881-6. PMID: 1415481
10. Keime-Guibert F, Graus F, Broët P, Reñé R, Molinuevo JL, Ascaso C, et al. Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor. Neurology. 1999 Nov 10; 53 (8):1719-23. PMID: 10563618
11. Maddison P, Newsom-Davis J, Mills KR, Souhami RL. Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma. Lancet. 1999 Jan 9; 353(9147):117-8.
12. Dalmau J, Furneaux HM, Gralla RJ, Kris MG, Posner JB. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer-a quantitative western blot analysis. Ann Neurol. 1990 May; 27 (5):544-52. PMID: 2163235
13. Darnell RB, DeAngelis LM. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet. 1993 Jan 2; 341(8836):21-2. PMID: 8093269
14. O'Neill JH, Murray NM, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain. 1988 Jun; 111 (Pt 3):577-96. PMID: 2838124
15. Graus F, Dalmau J, Reñé R, Tora M, Malats N, Verschuuren JJ, et al. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol. 1997 Aug; 15(8):2866-72. PMID: 9256130
16. Monstad SE, Drivsholm L, Storstein A, Aarseth JH, Haugen M, Lang B, et al. Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer. J Clin Oncol. 2004 Mar 1; 22(5):795-800. PMID: 14990634
17. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004 Aug; 75 (8):1135-40. PMID: 15258215
18. Shillito P, Molenaar PC, Vincent A, Leys K, Zheng W, van den Berg RJ, et al. Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol. 1995 Nov; 38(5):714-22. PMID: 7486862
19. Motomura M, Johnston I, Lang B, Vincent A, Newsom-Davis J. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry. 1995 Jan; 58(1):85-7. PMID: 7823075
20. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly nonparaneoplastic disorder of both sexes. Brain. 2010 Jun; 133(Pt 6):1655-67. doi: 10.1093/brain/awq113 PMID: 20511282
21. Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain. 2010 Sep; 133 (9):2734-48. doi: 10.1093/brain/awq213 PMID: 20663977
22. Chow S, Ruskey F. Towards a General Solution to Drawing Area-Proportional Euler Diagrams. Electronic Notes in Theoretical Computer Science. 2005; 134:3-18
23. Gozzard P, Woodhall M, Chapman C, Nibber A, Waters P, Vincent A, et al. Paraneoplastic neurologic disorders in small cell lung carcinoma: A prospective study. Neurology. 2015 Jul 21; 85(3):235-9 doi: 10.1212/WNL.0000000000001721 PMID: 26109714
24. Titulaer MJ, Klooster R, Potman M, Sabater L, Graus F, Hegeman IM, et al. SOX antibodies in smallcell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival. J Clin Oncol. 2009 Sep 10; 27(26):4260-7. doi: 10.1200/JCO.2008.20.6169 PMID: 19667272
25. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 1998 Jun 4; 393(6684):480-3. PMID: 9624005
26. Yu P, Spiotto MT, Lee Y, Schreiber H, Fu YX. Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells. J Exp Med. 2003 Apr 21; 197 (8):985-95. PMID: 12695490
27. Smyth MJ, Dunn GP, Schreiber RD. Cancer immunosurveillance and immunoediting: The roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol 90:1-50, 2006. PMID: 16730260
28. Eerola AK, Soini Y, Pääkkö P. A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma. Clin Cancer Res. 2000 May; 6(5):1875-81. PMID: 10815910
29. Björling E, Lindskog C, Oksvold P, Linné J, Kampf C, Hober S, et al. A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues. Mol Cell Proteomics. 2008 May; 7(5):825-44. PMID: 17913849
30. Lampson LA, Fisher CA. Weak HLA and beta 2-microglobulin expression of neuronal cell lines can be modulated by interferon. Proc Natl Acad Sci U S A. 1984 Oct; 81(20):6476-80. PMID: 6436814
31. Anderson DJ, Bach DL, Yunis EJ, DeWolf WC. Major histocompatibility antigens are not expressed on human epididymal sperm. J Immunol. 1982 Aug; 129(2):452-4. PMID: 6806369
32. Gnjatic S, Nishikawa H, Jungbluth AA, Güre AO, Ritter G, Jäger E, et al. NY-ESO-1: review of an immunogenic tumor antigen. Adv Cancer Res. 2006; 95:1-30. PMID: 16860654
33. Jungbluth AA, Chen YT, Stockert E, Busam KJ, Kolb D, Iversen K, et al. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer. 2001 Jun 15; 92(6):856-60. PMID: 11351307
34. Derbinski J, Kyewski B. How thymic antigen presenting cells sample the body's self-antigens. Curr Opin Immunol. 2010 Oct; 22(5):592-600. doi: 10.1016/j.coi.2010.08.003 PMID: 20832274
35. Katz-Levy Y, Neville KL, Girvin AM, Vanderlugt CL, Pope JG, Tan LJ, et al. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. J Clin Invest. 1999 Sep; 104(5):599-610. PMID: 10487774
36. Chan KH, Vernino S, Lennon VA. ANNA-3 anti-neuronal nuclear antibody: marker of lung cancerrelated autoimmunity. Ann Neurol. 2001 Sep; 50(3):301-11. PMID: 11558786